(Date:10/10/2008)... MILWAUKEE, Wis., Oct. 10 /PRNewswire/ -- More...the November presidential election. This is the,re...ives held on Thursday,Oct. 9, at all of the healt...sin. A total of 658 people signed up to vote at th...ere trained by the Wisconsin,Government Accountabi...
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall...eloper, manufacturer and supplier of premium,diagn...cts dedicated to,serving the healthcare needs of w...quarter and fiscal 2008 operating results on Tuesd...nction with the release, management will,host a co...
(Date:10/10/2008)..., Upon the completion of ...BS Division of CDM Media proudly announces their n...or chief information technology executives in heal... Summit will launch May 10-12, 2009 at the Four Se... Honolulu, HI (PRWEB) October 11, 2008 -- ...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVi...e management of Trace Life Sciences Inc.,(Trace), ... cyclotron,production facilities in Denton, Texas...., Indium-111, Iodine-123 and Thallium-201 used in,..., NuView Chairman and,CEO, stated that "We are con...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2(Date:10/9/2008)...op Line Clinical Results Expected in November 2008...- SCOLR Pharma, Inc.,(Amex: DDD ) announced today...or the third of its three pivotal trials to evalua...2-hour extended-release (ER) ibuprofen for,the ove... report top-line,results from this pivotal trial i...
(Date:10/8/2008)...cceptance Will Reduce Animal Use in Cosmetics and ...wire/ -- MatTek Corp. today announced,that results...oratory,"catch-up" validation study on MatTek,s Ep...est results demonstrated the required sensitivity ...lidated alternative to animal,testing for determin...
(Date:10/8/2008)... Cornell University Food Scientists Expand Testing...Activity Assay, PORTLAND, Maine, Oct. 8 /PRNewswi...d today with the release of results from a new stu...ther commonly consumed,fruits like apples, bananas...using the Cellular Antioxidant Activity (CAA) assa...
(Date:10/8/2008)... Exploratory study shows clinical improvement in ... (PAH), -- Current treatment options have limit...gressive and incurable blood vessel disease, -- ...eatment of certain cancers, known to inhibit ...ther explore potential of imatinib mesylate in PAH...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Researchers explore the antidepressant effects of ketamine 12404 1Researchers explore the antidepressant effects of ketamine 12404 2A device that measures optimum state of an organ prior to transplanting has been patented 12401 1A device that measures optimum state of an organ prior to transplanting has been patented 12401 2National Lung Cancer partnership 12400 1National Lung Cancer partnership 12400 2Cleveland Clinic Collaborates with Google 12397 1Cleveland Clinic Collaborates with Google 12397 2Cleveland Clinic Collaborates with Google 12397 3Cleveland Clinic Collaborates with Google 12397 4...Up to 88% Efficacy, SEOUL, Korea, March 28, 2007 /...d today that it has completed a 340 patient phase,...long acting (12,hour half-life) oral phosphodieste...ion (ED). The multi-center study conducted in the,...olled study,designed to investigate the efficacy ...
...medical and economic advantages of nifedipine,GITS...7 – Two recently,published articles in the J...idence that the use of the long-acting calcium cha...has additional,benefits beyond its blood pressure ...al. (Journal of Clinical Epidemiology,2007; first ...
Other Medicine Technology:Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 2Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 3Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 4Calcium Channel Blocker Adalat GITS Offer Additional Benefits 2Calcium Channel Blocker Adalat GITS Offer Additional Benefits 3Colibri style tips with 0.12 mm, 1 x 2 teeth. Round knurled handle with alignment pin and polished finish.
Stainless steel model of the popular Nordan titanium Colibri forceps. Tying platform with 0.12 mm teeth for grasping delicate structures. Flattened round handle with polished finish.
Also referred to as McLean-Putney suture forceps. Slightly curved 6 mm long platform. Serrated handle with polished finish. Most popular size or model.
Oval solid 15 mm wide lower plate. Open upper plate with inside dimensions 11 mm x 8 mm. Serrated handle with locking thumb screw and polished finish.
Medicine Products: